Thursday, May 30, 2013
Two GlaxoSmithKline Drugs Approved by FDA
Two new GlaxoSmithKline drugs to treat advanced skin cancer, Tafinlar (dabrafenib) and Mekinist (trametinib), were granted Food and Drug Administration approval on Tuesday. GSK's national headquarters are located in Durham in Research Triangle Park.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment